The FDA is postponing the Feb. 15 Vaccines and Related Biological Products Advisory Committee meeting given new data that have recently emerged regarding Pfizer’s emergency use authorization request for the use of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months through 4 years of age.
Read more: Coronavirus (COVID-19) Update: FDA Postpones Advisory Committee Meeting to Discuss Request for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age